The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAssura Regulatory News (AGR)

Share Price Information for Assura (AGR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 42.60
Bid: 42.48
Ask: 42.56
Change: -0.08 (-0.19%)
Spread: 0.08 (0.188%)
Open: 42.86
High: 42.86
Low: 42.10
Prev. Close: 42.68
AGR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Notice of Dividend

29 Feb 2024 07:00

RNS Number : 8595E
Assura PLC
29 February 2024
 

 

29 February 2024

Assura plc

 

Notice of Dividend

 

Assura plc ("Assura" or "the Company"), the UK's leading primary care property investor and developer, today announces that the next quarterly interim dividend of 0.82 pence per share will be paid on 10 April 2024 to shareholders on the register on 8 March 2024 (the "Record Date"). The Ex-dividend Date will be 7 March 2024.

 

This interim dividend will be wholly Property Income Distribution ("PID"). Forms to register for gross PIDs are available on the Company's website and must be returned to the Company registrars, Link Group at 10th Floor, Central Square, 29 Wellington Street, Leeds, LS1 4DL to arrive by 4.30pm on 26 March 2024.Please refer to Company's website HERE for more information.

 

Shareholders may choose for the dividend to be paid either as cash or to be settled in New Shares via the Scrip Dividend Alternative. The Scrip Dividend Alternative price is to be calculated using the average of the middle market quotations for an Ordinary Share, as derived from the Daily Official List of the London Stock Exchange, for the five consecutive business days commencing on the Ex-dividend Date and will be announced by the Company and detailed on the Company's website on 14 March 2024.

 

Any shareholders wishing to take up the Scrip Dividend Alternative, who have not already done so, will have until 4.30pm on 26 March 2024 either to return their completed mandate form to the Company registrars, Link Group at 10th Floor, Central Square, 29 Wellington Street, Leeds, LS1 4DL (in the case of shareholdings in certificated form) or to take the necessary action via the CREST system (in the case of shareholdings in uncertificated form).

 

The Circular concerning this Scrip Dividend Alternative is available on the Company's website, www.assuraplc.com and is also available for inspection at the National Storage Mechanism https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

 

- Ends -

 

For more information, please contact:

 

Assura plc David Purcell, Investor Relations Director

Tel: 0161 515 2043 Email: Investor@assura.co.uk

 

FGS Global

Gordon Simpson

 

Tel: 0207 251 3801 Email: Assura@fgsglobal.com

 

 

 Notes to Editors

Assura plc is a national healthcare premises specialist and UK REIT based in Altrincham, UK - caring for more than 600 primary healthcare buildings, from which over six million patients are served.

 

A constituent of the FTSE 250 and the EPRA* indices, as at 30 September 2023, Assura's portfolio was valued at £2.7 billion.

 

At Assura, we BUILD for health. Assura builds better spaces for people and places, invests in skills and inspires new ways of working, and unlocks the power of design and innovation to deliver lasting impact for communities - aiming for six million people to have benefitted from improvements to and through its healthcare buildings by 2026. 

 

Assura is leading for a sustainable future, targeting net zero carbon across its portfolio by 2040.

 

Further information is available at www.assuraplc.com

 

*EPRA is a registered trademark of the European Public Real Estate Association.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DIVPPUAUPUPCGRR
Date   Source Headline
15th Jun 20213:30 pmRNSHolding(s) in Company
11th Jun 20215:24 pmRNSHolding(s) in Company
10th Jun 20213:03 pmRNSHolding(s) in Company
8th Jun 20214:27 pmRNSDirector/PDMR Shareholding
4th Jun 20217:00 amRNSAnnual Report & Notice of AGM
3rd Jun 20214:03 pmRNSHolding(s) in Company
3rd Jun 20218:38 amRNSDirector/PDMR Shareholding
3rd Jun 20217:00 amRNSNotice of Dividend
2nd Jun 20217:00 amRNSDevelopment update
27th May 20218:55 amRNSHolding(s) in Company
18th May 20211:03 pmRNSHolding(s) in Company
18th May 20217:00 amRNSAssura Full Year Results 2021
7th May 20211:24 pmRNSDirector/PDMR Shareholding
4th May 20218:08 amRNSHolding(s) in Company
30th Apr 20217:00 amRNSTotal Voting Rights
22nd Apr 20217:00 amRNSNotice of Results
16th Apr 202110:01 amRNSDirector/PDMR Shareholding
12th Apr 20217:00 amRNSScrip Dividend Declaration
8th Apr 20217:00 amRNSAdditional Listing
7th Apr 20214:09 pmRNSDirector/PDMR Shareholding
6th Apr 20217:00 amRNSDirectorate Change
31st Mar 20218:47 amRNSHolding(s) in Company
25th Mar 20214:05 pmRNSHolding(s) in Company
22nd Mar 20217:50 amRNSHolding(s) in Company
18th Mar 202111:50 amRNSScrip Calculation Price
9th Mar 20212:16 pmRNSHolding(s) in Company
9th Mar 20217:00 amRNSInvestor Presentation
8th Mar 202110:05 amRNSDirector/PDMR Shareholding
4th Mar 20217:00 amRNSNotice of Dividend
19th Feb 20217:00 amRNSAcquisition of Apollo
11th Feb 20214:25 pmRNSExercise of Nil Cost Options under PSP
11th Feb 20211:31 pmRNSHolding(s) in Company
8th Feb 20213:13 pmRNSDirector/PDMR Shareholding
5th Feb 20219:18 amRNSAdditional Listing
26th Jan 20213:47 pmRNSHolding(s) in Company
18th Jan 20213:57 pmRNSDirector/PDMR Shareholding
11th Jan 20217:00 amRNSScrip Dividend Declaration
11th Jan 20217:00 amRNSTrading Update
6th Jan 202112:18 pmRNSDirector/PDMR Shareholding
6th Jan 202110:03 amRNSDirector/PDMR Shareholding
17th Dec 20204:47 pmRNSScrip Calculation Price
16th Dec 20209:43 amRNSHolding(s) in Company
9th Dec 202010:42 amRNSDirector/PDMR Shareholding
8th Dec 20204:29 pmRNSHolding(s) in Company
3rd Dec 20207:00 amRNSNotice of Dividend
2nd Dec 20202:49 pmRNSHolding(s) in Company
1st Dec 20209:01 amRNSHolding(s) in Company
26th Nov 20203:23 pmRNSHolding(s) in Company
18th Nov 20205:33 pmRNSHolding(s) in Company
17th Nov 20207:00 amRNSInterim Results 2020

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.